Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sintez-CIP is a Russian pharmaceutical manufacturing company and a member of the PIK-PHARMA group of companies. Based in Belgorod, the company specializes in the development and industrial production of active pharmaceutical ingredients (APIs), with a primary focus on iron-containing complexes. Its flagship products include Iron (III) hydroxide polymaltose complex and Iron (III) hydroxide sucrose complex, which are essential for treating iron deficiency anemia. Sintez-CIP operates modern manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. The company plays a critical role in the Russian pharmaceutical industry's import substitution efforts by providing high-quality chemical substances for domestic drug production. Their core expertise lies in complex chemical synthesis and the production of stable metal-organic coordination compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sintez-CIP.